Credit Suisse Group downgraded shares of Xylem (NYSE:XYL) from an outperform rating to a neutral rating in a report published on Friday, BenzingaRatingsTable reports.
Several other research firms have also recently weighed in on XYL. Stifel Nicolaus cut their price objective on Xylem from $93.00 to $89.00 and set a buy rating for the company in a research report on Friday, May 3rd. Cowen cut Xylem from an outperform rating to a market perform rating and cut their price objective for the stock from $75.00 to $72.00 in a research report on Tuesday, May 14th. Janney Montgomery Scott raised Xylem from a neutral rating to a buy rating and set a $86.00 price objective for the company in a research report on Friday, May 3rd. ValuEngine cut Xylem from a buy rating to a hold rating in a research report on Thursday. Finally, Zacks Investment Research raised Xylem from a sell rating to a hold rating in a research report on Saturday, April 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average price target of $79.69.
Shares of XYL traded down $1.28 during trading hours on Friday, hitting $77.53. 966,069 shares of the company were exchanged, compared to its average volume of 674,349. The company has a market capitalization of $14.45 billion, a P/E ratio of 26.92, a PEG ratio of 1.51 and a beta of 1.19. The company’s 50 day simple moving average is $81.72. Xylem has a 52 week low of $60.65 and a 52 week high of $85.39. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.02 and a current ratio of 1.44.
In other Xylem news, SVP Claudia S. Toussaint sold 2,344 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $78.53, for a total value of $184,074.32. Following the completion of the transaction, the senior vice president now owns 43,761 shares of the company’s stock, valued at approximately $3,436,551.33. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Pak Steven Leung sold 8,947 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $78.55, for a total value of $702,786.85. Following the completion of the transaction, the senior vice president now directly owns 42,980 shares of the company’s stock, valued at approximately $3,376,079. The disclosure for this sale can be found here. Insiders have sold a total of 46,818 shares of company stock valued at $3,747,594 in the last three months. 0.85% of the stock is owned by insiders.
A number of institutional investors have recently bought and sold shares of the business. Gofen & Glossberg LLC IL bought a new stake in shares of Xylem in the 1st quarter valued at approximately $208,000. Gulf International Bank UK Ltd grew its position in Xylem by 1.9% during the 1st quarter. Gulf International Bank UK Ltd now owns 44,560 shares of the industrial products company’s stock worth $3,522,000 after acquiring an additional 830 shares during the last quarter. Peoples Financial Services CORP. grew its position in Xylem by 2.9% during the 1st quarter. Peoples Financial Services CORP. now owns 8,938 shares of the industrial products company’s stock worth $706,000 after acquiring an additional 250 shares during the last quarter. BlackRock Inc. grew its position in Xylem by 3.6% during the 1st quarter. BlackRock Inc. now owns 14,986,762 shares of the industrial products company’s stock worth $1,184,554,000 after acquiring an additional 516,715 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in Xylem by 48.8% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,438 shares of the industrial products company’s stock worth $204,000 after acquiring an additional 800 shares during the last quarter. 85.37% of the stock is owned by hedge funds and other institutional investors.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
See Also: Death Cross
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.